Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
56.7%
% of PJP's 30 holdings also in FTXH
34.0%
% of FTXH's 51 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 5.3% | 8.1% | 5.3% |
|
MERCK & CO. INC. | 4.8% | 7.1% | 4.8% |
|
ABBVIE INC | 4.8% | 7.0% | 4.8% |
|
PFIZER INC | 4.7% | 7.1% | 4.7% |
|
GILEAD SCIENCES INC | 5.3% | 3.9% | 3.9% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to FTXH
|
ABBOTT LABORATORIES | 5.4% |
|
BIOSANTE PHARMACEUTICALS INC | 3.9% |
|
TARSUS PHARMACEUTICALS, INC. | 3.7% |
|
INNOVIVA, INC. | 3.1% |
|
PACIRA PHARMACEUTICALS INC | 3.0% |
|
SUPERNUS PHARMACEUTICALS INC | 2.9% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 2.9% |
|
LIQUIDIA TECHNOLOGIES, INC. | 2.7% |
|
LIGAND PHARMACEUTICALS-CL B | 2.7% |
|
CORCEPT THERAPEUTICS INC | 2.5% |
PJP Underweight Relative to FTXH
|
BRISTOL-MYERS SQUIBB CO | -4.4% |
|
ZOETIS INC | -3.8% |
|
JOHNSON & JOHNSON | -2.7% |
|
PFIZER INC | -2.4% |
|
MERCK & CO. INC. | -2.3% |
|
ORGANON & CO. | -2.3% |
|
ABBVIE INC | -2.2% |
|
EXELIXIS INC | -2.1% |
|
MEDPACE HOLDINGS, INC. | -1.9% |
|
HALOZYME THERAPEUTICS INC | -1.6% |